Effect of DHA on breath holding spells in children
Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial
This study is testing if giving DHA, an omega-3 fatty acid, can help reduce the number and severity of breath holding spells in children.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 1 Month to 5 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT03965988 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of docosahexaenoic acid (DHA) on children experiencing breath holding spells. It is a Phase 3 interventional study where participants will receive either DHA or a placebo to assess the effectiveness of DHA in reducing the frequency and severity of these spells. The study aims to provide a clearer understanding of how DHA supplementation may benefit affected children. The trial will involve monitoring participants over a specified period to evaluate outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are children who have been newly diagnosed with breath holding spells.
Not a fit: Patients currently receiving other treatments such as iron or piracetam may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new dietary intervention for managing breath holding spells in children.
How similar studies have performed: There is limited information on similar studies, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with newly diagnosed sprlls Exclusion Criteria Other treatment as iron and piracetam
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: Amira Darwish, Lecturer — Tanta University - Faculty of Medicine
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.